Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Nifurtimox

An antiparasitic of the nitrofuran family, in use since 1965 against Chagas disease; together with eflornithine it is also used against the advanced stage of African sleeping sickness, and in 2020 it was approved in the United States for children. This family brings together the active ingredient and labelled standards.

Did you know?It is the parasite itself that activates it: it converts it into a radical that damages its own DNA, while human cells defend themselves with antioxidant enzymes such as catalase.

NifurtimoxGo to the active ingredient →
NifurtimoxActive ingredientNifurtimoxCat. No. P-N061-001CAS 23256-30-6

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.